Prajna, NV
Lalitha, P
Sharma, S
de Freitas, D
Höfling-Lima, A
Varnado, N
Abdelrahman, S
Cavallino, V
Arnold, BF
Lietman, TM
Rose-Nussbaumer, J
Article History
Received: 25 March 2024
Accepted: 6 August 2024
First Online: 28 August 2024
Declarations
:
: Single IRB approval for US sites was obtained at the University of California, San Francisco (#1826045). Institutional IRB approval was obtained at the Aravind Eye Hospital, Madurai (2020009CLI). Council on Medical Research (ICMR) approval was also obtained for the study (011–26589492). Institutional IRB approval was obtained from the University Hospital of São Paulo (IRB# 482/21) and Brazilian government approval was obtained as well (CONEP# 5.900.981).
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.
: There are no conflicts of interest to report.